Eko Stock

Eko creates FDA approved software, AI, and heart sound and EKG sensors for heart disease monitoring.

Sign up today and learn more about Eko Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Eko Stock

Eko Devices harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sounds to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko Devices was established in 2013 and is based in Berkeley, California.

Funding History

January 2014$800K
January 2015$0
March 2015$2.0M
March 2018$5.0M


Co-Founder & CTO

Tyler Crouch

VP of Products

Philip Goolkasian

Co-Founder & COO

Jason Bellet

Co-Founder & CEO

Connor Landgraf


Wall Streets Journal - Apr, 25 2019

The Humble Stethoscope Gets a High-Tech Makeover

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: